A Cardiac Safety Study of an Investigational Drug to See How if Affects the Heart in People With Parkinson's Disease Complicated by Motor Fluctuations "OFF" Episodes

NCT03187301 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson's Disease
Off Episodes of Parkinson Disease

Interventions

DRUG: APL-130277
DRUG: Placebo
DRUG: Moxifloxacin

Sponsor

Sumitomo Pharma America, Inc.